SE OF DEXMEDETOMIDINE AND BENZODIAZEPINES IN SEVERE ALCOHOL WITHDRAWAL FOR SEDATIO
Phase 4
- Conditions
- Health Condition 1: F101- Alcohol abuse
- Registration Number
- CTRI/2024/04/065482
- Lead Sponsor
- Pradeep S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with severe alcohol withdrawal(F10.231) as defined BY ICD-10 guidelines
Exclusion Criteria
Patient under 18 years of age,pregnant women,patients with limited life expectancy due to chronic diseases,patients with pre existing neurological illness,Concomitant Substance abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare differences in Median Benzodiazepine Dose in the First 24-hour among two study groups for maintaining light to moderate sedation with target RASS score of 0 to -2.Timepoint: 24 hours
- Secondary Outcome Measures
Name Time Method ength of ICU stay, sedation quality, The ability to communicate, Haloperidol requirements, CIWA-Ar Score during admission and after 24 hours between two groupsTimepoint: Throughout ICU/ED Admission